Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia.
Pratz KW, Kaplan J, Levy M, Bixby D, Burke PW, Erba H, Wise-Draper TM, Roboz GJ, Papadantonakis N, Rajkhowa T, Hernandez D, Dobler I, Gregory RC, Li C, Wang S, Stumpo K, Kannan K, Miao H, Levis M. Pratz KW, et al. Among authors: burke pw. Haematologica. 2023 Mar 1;108(3):705-716. doi: 10.3324/haematol.2022.281216. Haematologica. 2023. PMID: 36226495 Free PMC article. Clinical Trial.
Minimizing waste during preparation of blinatumomab infusions.
Marini BL, Wechter AR, Burke PW, Bixby D, Perissinotti AJ. Marini BL, et al. Among authors: burke pw. Am J Health Syst Pharm. 2016 Jan 15;73(2):19-20. doi: 10.2146/ajhp150420. Am J Health Syst Pharm. 2016. PMID: 26721530 No abstract available.
Catalyzing improvements in ALL therapy with asparaginase.
Marini BL, Perissinotti AJ, Bixby DL, Brown J, Burke PW. Marini BL, et al. Among authors: burke pw. Blood Rev. 2017 Sep;31(5):328-338. doi: 10.1016/j.blre.2017.06.002. Epub 2017 Jul 5. Blood Rev. 2017. PMID: 28697948 Review.
Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019.
Brown PA, Wieduwilt M, Logan A, DeAngelo DJ, Wang ES, Fathi A, Cassaday RD, Litzow M, Advani A, Aoun P, Bhatnagar B, Boyer MW, Bryan T, Burke PW, Coccia PF, Coutre SE, Jain N, Kirby S, Liu A, Massaro S, Mattison RJ, Oluwole O, Papadantonakis N, Park J, Rubnitz JE, Uy GL, Gregory KM, Ogba N, Shah B. Brown PA, et al. Among authors: burke pw. J Natl Compr Canc Netw. 2019 May 1;17(5):414-423. doi: 10.6004/jnccn.2019.0024. J Natl Compr Canc Netw. 2019. PMID: 31085755 Review.
Mini-HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?
Marini BL, Perissinotti AJ, Bixby DL, Burke PW, Pettit KM, Benitez LL. Marini BL, et al. Among authors: burke pw. Cancer. 2019 Nov 1;125(21):3890-3891. doi: 10.1002/cncr.32381. Epub 2019 Jul 10. Cancer. 2019. PMID: 31291001 Free article. No abstract available.
51 results